| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5509931 | Clinical Biochemistry | 2017 | 5 Pages |
Abstract
Our findings suggest that a single assessment of P-Selectin, TM, TPO and GPIIb/IIIa at baseline in prospective epidemiological studies is appropriate to investigate associations between platelet activation and risks of chronic diseases.
Keywords
EPICECLIAP-selectinHbA1cICCHDLTPOhigh-density lipoproteinElectrochemiluminescence immunoassaycardiovascular diseaseEuropean Prospective Investigation into Cancer and NutritionThrombomodulinThrombopoietinEnzyme-linked immunosorbent assayELISAIntra-individual variationCVDCoefficient of VariationLow-density lipoproteinLDLGlycated hemoglobin A1cC-reactive proteinCRPquality controlGlycoproteinglycoprotein IIb/IIIa
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Mirja E. Graf, Disorn Sookthai, Theron Johnson, Ruth Schübel, Verena Katzke, Peter Bugert, Michael Hoffmeister, Rudolf Kaaks, Tilman Kühn,